In what could be a major breakthrough for antibiotic research, Mumbai-based Wockhardt is all set to launch its novel antibiotic candidate WCK 5222, or Zaynich, in India by the end of 2024-25, followed by a global launch in 2025-26. The total addressable market for the antibiotic is estimated to be around $25 billion globally.
Wockhardt expects no competition for this drug worldwide for at least the next 15 years as there is no other similar drug in research pipelines. In India, around 750,000 patients are suffering from antimicrobial resistance (AMR), while in the US this number is around 500,000 and in the EU it is about 700,000. According to Wockhardt Chairman Habil Khorakiwala, the price of the antibiotic in India would be one-tenth of its global price.
Zaynich a combination of Zidebactam and Cefepime is effective in treating infections caused by drug-resistant pathogens. Basically, the drug is effective against all major superbugs that have become resistant to almost all antibiotics used today - often referred to as multi-drug resistant (MDR), or extensively drug resistant (XDR) pathogens.
Globally, mortality rate in patients infected with MDR superbugs is in excess of 30 per cent.
Denne historien er fra June 29, 2024-utgaven av Business Standard.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra June 29, 2024-utgaven av Business Standard.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Trade on road to recovery but Indian firms tread cautiously
The concluding part of the series highlights stabilising trade ties with Dhaka, but payment delays anda complex bilateral environment remain major concerns
DoT launches new system to block fraud international calls
The Department of Telecommunications (DoT), in collaboration with Telecom Service Providers (TSPs), has introduced an advanced system designed to identify and block incoming international spoofed calls before they can reach Indian telecom subscribers.
PM to launch infra projects, agri schemes in Maha today
Prime Minister Narendra Modi will on Saturday inaugurate infrastructure projects worth ₹32,180 crore in election-bound Maharashtra.
The shrinking presence of smaller parties in Haryana Assembly polls
Since 2014, Haryana's electoral politics has seen smaller parties cede their vote shares to the Bharatiya Janata Party (BJP) and the Congress, a trend that these political parties would hope to buck in this Assembly polls.
DMart stock slips despite strong showing in Q2
Mixed response from brokerages; company had 377 stores till Sep 30
Jio Fin-BlackRock JV gets Sebi approval for MF entry
Jio Financial Services' joint venture with BlackRock to enter the mutual fund (MF) space in India has received the nod from the Securities and Exchange Board of India (Sebi), the firm stated in an exchange filing on Friday.
HDFC BANK'S MSCI WEIGHT SET TO RISE
India's largest private sector lender HDFC Bank is poised to see its weighting increase further in global services provider MSCI indices due to its expanded foreign portfolio investor (FPI) investment headroom.
"The mother of all bear mkts in equities is dead"
Developments in West Asia have triggered a panic-like situation across global equity markets. SHANKAR SHARMA, founder of wealth management firm GQuant Investech, spoke with Puneet Wadhwa in New Delhi about escalating tensions between Israel and Iran. Edited excerpts:
Higher e-auction share crucial for Coal India stock
Coal India (CIL) has reported a production of 51 million tonnes (mt) for September, up 10.4 per cent month-on-month (M-o-M), but down 1 per cent year-on-year (Y-o-Y).
Sebi proposes measures to boost retail participation in G-Sec mkt
The Securities and Exchange Board of India (Sebi) is considering initiatives to promote retail participation in government securities (G-Secs) through stock brokers.
